Interview with Kleiner Device Labs
Earlier this week, we had the chance to interview Mike Hughes – Chief Commercial Officer at Kleiner Device Labs (KDL) – and had the chance to dive into several different topics about the company and opportunity.
This guide is brought to you by Equifund, LLC.
If you have money saved in a retirement account – like 401k, 403b, IRA, or Roth IRA – your investment options are likely restricted to things like stocks, bonds, and mutual funds.
But according to ProPublica, wealthy Americans have been using their retirement accounts to invest in Pre-IPO investments to create a tax advantaged fortune!
The most notable example being the founder of PayPal – and now billionaire venture capitalist – Peter Thiel.
According to the same ProPublica article Thiel started a Roth IRA in 1999 with assets that at the time were worth less than $2,000. Those assets are now valued at $5 billion.
How did he do it?
It all has to do with this little-known account that “unlocks” your retirement assets.
For the full details, read our free guide called Pre-IPO Retirement Accounts: How to Invest in Pre-IPO Investments With a Self-Directed IRA
Yours for investing equality,
Jordan Gillissie – CEO
Equifund
Earlier this week, we had the chance to interview Mike Hughes – Chief Commercial Officer at Kleiner Device Labs (KDL) – and had the chance to dive into several different topics about the company and opportunity.
This deep dive webinar is designed for anyone who wants to learn more about investing in Telehealth and Remote Patient Monitoring deals. It doesn’t matter if you’re a Wall Street Insider or you’re brand new to investing, this training is for you.
In our latest addition to Equifund’s CEO Interview Series, we sit down with Fernando Berdegué, CEO of Durango Gold to get an update on the company’s exploration progress, ESG outlook, IPO plans, and more.
Before you let the FOMO trick you into dumping cash into the “next big thing”, watch this webinar to see how we here at Equifund look at trends and “hot” investing opportunities.
By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.
Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.
Over 20 patents have been issued to protect the company's technologies.
Just received FDA clearance for their next-generation KG2 spinal fusion technology.
The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO
Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:
We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.
Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.
If you have not received the email in 5 minutes, please click here to have it resent.
Questions? Our customer service team is always here to help – 1-866-338-3004